## CPRT: Copart, Inc. - XLI: Industrials

### Executive Summary

No thesis match: MRS_10 0.2% below STRENGTH zone (3.0-6.0%); PEG 3.40 fails VALUE criteria (<1.0). Stock is in no-man's land without clear edge.

- **Horizon:** N/A - no position
- **Risk Profile:** N/A - avoiding
- **Stop Type:** Fixed 2xATR ($38.24)
- **If Wrong:** N/A - wait for clearer setup
- **Invalidation:** MRS_10 falling below -5% or breaking key support

### News

- **Articles:** 3
- **Sentiment:** Neutral (Bullish: 0, Bearish: 0)

**1. PineStone Asset Management Inc. Has $347.29 Million Holdings in Copart, Inc. $CPRT**
- Source: MarketBeat | 20251228T125403 | Neutral | Relevance: 100%
- PineStone Asset Management Inc. significantly increased its stake in Copart, Inc. (NASDAQ:CPRT) by 20.5% in the third quarter, bringing its total holdings to 7,722,652 shares valued at $347.29 million. Despite this institutional buying, several insiders, including CEO Jeffrey Liaw and Director Thomas N. Tryforos, sold substantial amounts of their shares, reducing their personal holdings. Copart trades near its 52-week low with a "Moderate Buy" consensus rating and a target price of $47.60 from analysts.

**2. Pacer Advisors Inc. Has $17.07 Million Stock Holdings in Copart, Inc. $CPRT**
- Source: MarketBeat | 20251228T111111 | Neutral | Relevance: 100%
- Pacer Advisors Inc. significantly increased its stake in Copart, Inc. (NASDAQ:CPRT) by 15.3% in Q3, now holding 379,626 shares valued at $17.07 million. This move comes amidst notable insider selling, with a director and the CEO divesting substantial shares. Analysts maintain a "Moderate Buy" consensus for Copart with a target price of $47.60, as the company reported a Q3 EPS of $0.41, exceeding estimates, despite slightly missing revenue expectations.

**3. FTC delay derails Veriskâ€“AccuLynx deal and prompts $1.5B note buyback**
- Source: Stock Titan | 20251229T134657 | Neutral | Relevance: 55%
- Verisk (Nasdaq: VRSK) has terminated its agreement to acquire AccuLynx because the Federal Trade Commission did not complete its review by the contractual deadline. Consequently, Verisk will redeem $1.50 billion in senior notes issued for the acquisition at 101% of principal plus accrued interest. AccuLynx disputes the termination, but Verisk intends to defend its position.

### Insider Activity (90 days)

| Metric | Value |
|--------|-------|
| Direction | **NET_SELLING** |
| Buys | 11 ($0.38M) |
| Sells | 2 ($5.09M) |

### Institutional Ownership

| Metric | Value |
|--------|-------|
| Total Ownership | 37.9% |
| Smart Money | **BULLISH** |
| Net Flow | 0.0% |
| Buying/Selling | 6 / 4 |

**Top Holders:**
- Vanguard Group Inc: 11.3% (+2.4%)
- Blackrock Inc.: 6.5% (-2.4%)
- Principal Financial : 4.2% (+3.2%)
- State Street Corpora: 3.8% (+1.8%)
- JPMORGAN CHASE & CO: 2.7% (+86.7%)

### Key Risks

1. Insider selling cluster: $5.1M in recent transactions.
2. Valuation stretched: PEG 3.4x requires aggressive growth execution.
3. Long-term trend broken: trading 18.6% below SMA200.

### Catalysts

- AI/machine learning initiatives could drive multiple expansion if executed.
- Momentum building: MRS_10 improving +1.2% over 5 days suggests accumulation.

### Fundamentals

PEG ratio 3.40 signals overvaluation risk, limited margin of safety. Forward P/E 21.9x stretched relative to 10% growth. Quality metrics strong (ROA 11%, margin 34%). Balance sheet: strong liquidity (7.9x), low leverage (D/E 0.10). Insider selling cluster ($5.1M in 90 days), potential headwind. Institutional flow bullish (6 buying vs 4 selling).

| Metric | Value |
|--------|-------|
| Market Cap | $38.2B |
| Beta | 1.12 |
| 52W Range | $38.18 - $63.85 |
| Short Interest | 3.8% |

| Valuation | Value |
|-----------|-------|
| PEG Ratio | 3.40 |
| Forward P/E | 21.9 |
| Current P/E | 24.0 |
| YoY Growth | 9.7% |
| EPS Direction | STABLE |

### Technicals

MRS_10 strengthening from -1.0% to 0.2% (+1.2% in 5 days), confirming momentum buildup. Below STRENGTH zone by 2.8pp (needs >3.0% for momentum thesis). MRS_5 at 1.0% confirms short-term momentum alignment. Below SMA200 (0.81x), long-term trend not supportive. RSI neutral at 48. OFD pattern: +SUL (Resistance test).

| Metric | Value | Signal |
|--------|-------|--------|
| MRS_10 | 0.21% (CS: 67) | Neutral |
| RSI_14 | 48.4 | Neutral |
| MACD Histogram | 0.21 | Bullish |
| vs SMA20 | 1.013x | Above |
| vs SMA50 | 0.970x | Below |
| vs SMA200 | 0.814x | Below |

### Decision

- **Verdict:** AVOID
- **Thesis:** NEUTRAL

### Trade Setup

- **Entry:** $39.50
- **Stop Loss:** $38.24 (3.2% risk)
- **Target:** $40.76 (R:R method)
- **Risk/Reward:** 1.00:1
- **Target Reasoning:** NEUTRAL thesis targets 1.0x risk/reward based on historical edge

### Position Sizing

- **Shares:** 1047
- **Position Value:** $41,356.50
- **Portfolio %:** 41.36%
- **Risk Dollars:** $1,320.00
- **Risk Per Trade:** 1.32%
- **Modifiers:** L1 110% | L2 120% | Combined 1.32x

### Market Context

| Layer | Signal | Modifier |
|-------|--------|----------|
| L1 Macro | NORMAL (HIGH) | 1.10x |
| L2 Sector | TREND (Zone A) | 1.20x |

*NORMAL regime with balanced risk signals and moderate market participation. VIX at 14.33 indicates calm conditions, while positive yield curve (+59bps) and stable economic data support continued expansion. Year-end positioning and Fed uncertainty create near-term caution, but no systemic risks evident.*

### Earnings

**Next:** 2026-02-19 (Est: $0.39)

| Quarter | Est | Actual | Surprise |
|---------|-----|--------|----------|
| 2025Q4 | $0.39 | $0.41 | +5.1% |
| 2025Q3 | $0.36 | $0.41 | +13.3% |
| 2025Q2 | $0.42 | $0.42 | +0.8% |
| 2025Q1 | $0.37 | $0.40 | +7.5% |

---
*RULE-based L3 | 2026-01-06 16:37 | MRS_10*